MTOR and hepatocellular carcinoma: These data in HCC tissues suggested mTOR signalling pathway and DNMT1 might affect cell proliferation and the combination of DNMT1 and p-mTOR levels could represent a more powerful criterion for predicting HCC patients’ survival.